TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS (TRICERATOPS)
A Randomized Placebo-Controlled TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS- The TRICERATOPS Study
A Randomized Placebo-Controlled TRIal of PPF3 vs. PlaCEbo in the TReatment of children and AdolescenTs with NeurOdeveloPmental DisorderS
研究概览
研究类型
注册 (估计的)
阶段
- 阶段2
联系人和位置
学习联系方式
- 姓名:Ches Souru, MD
- 电话号码:3297 416-425-6220
- 邮箱:csouru@hollandbloorview.ca
研究联系人备份
- 姓名:Evdokia Anagnostou, MD
- 电话号码:416-753-6005
- 邮箱:eanagnostou@hollandbloorview.ca
学习地点
-
-
Ontario
-
Hamilton、Ontario、加拿大、L8L 0A4
- 尚未招聘
- McMaster University
-
接触:
- Shamama Raza
- 电话号码:3297 razas19@mcmaster.ca
- 邮箱:razas19@mcmaster.ca
-
首席研究员:
- Elisabetta Trinari, MD
-
Kingston、Ontario、加拿大、K7L 3N6
- 尚未招聘
- Queen's University
-
接触:
- Stamatoula Pasvanis
- 电话号码:76923 613-533-6000
- 邮箱:s.pasvanis@queensu.ca
-
首席研究员:
- Marc Woodbury-Smith, MD
-
London、Ontario、加拿大、N6A 5W9
- 尚未招聘
- London Health Sciences Centre
-
首席研究员:
- Janys Lim, MD
-
接触:
- Kayleigh Tam
- 电话号码:75556 519.685.8500
- 邮箱:Kayleigh.Tam@lhsc.on.ca
-
Toronto、Ontario、加拿大、M4G 1R8
- 招聘中
- Holland Bloorview Kids Rehabilitation Hospital
-
首席研究员:
- Evdokia Anagnostou, MD
-
接触:
- Ches Souru, MD
- 电话号码:3297 416-425-6220
- 邮箱:csouru@hollandbloorview.ca
-
接触:
- Evdokia Anagnostou, MD
- 电话号码:416-753-6005
- 邮箱:eanagnostou@hollandbloorview.ca
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Outpatients 8-17 years of age, inclusive, with a weight ≥ 30 kg.
-
Already have participated in POND cohort
-
Females of childbearing potential who are sexually active and agree to use medically acceptable birth control throughout the study and at least one week post last dose of study drug.
-
Meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria (American Psychiatric Association, 2013) for ASD. Diagnosis will be supported by the ADOS-2. Diagnostic and Statistical Manual (DSM-5) criteria will be established by a clinician with expertise with individuals with ASD.
-
Have a Clinical Global Impression-Severity (CGI-S; Guy, 1976)) score ≥ 4 (moderately ill)
-
If already receiving interventions, must meet the following criteria:
-
If receiving concomitant medications affecting behaviour, must be on a stable dose during the month prior to screening (6 weeks for Fluoxetine) and will not electively modify ongoing medications for the study duration.
b. If already receiving stable non-pharmacological behavioural interventions, have stable participation during 3 months prior to screening, and will not electively modify ongoing interventions.
-
Have a negative pregnancy test at screening for patients who have experienced menarche
-
Have normal physical examination and laboratory test results at Screening. If abnormal, the finding(s) must be deemed clinically insignificant by the Qualified Investigator.
Ability to obtain written informed consent from the participant, if developmentally appropriate. If a participant does not have the capacity to consent, ability to obtain assent (if developmentally appropriate), as well as written informed consent from their parent(s)/legal guardian.
Exclusion Criteria:
Please contact the site for details
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Arm 1
PPF3 |
Investigational |
|
安慰剂比较:Arm 2
Placebo |
Placebo |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Adverse event
大体时间:From enrollment to the end of week 16
|
From enrollment to the end of week 16
|
|
Clinical Global Impression Scale
大体时间:From Screening to Week 16
|
From Screening to Week 16
|
合作者和调查者
调查人员
- 首席研究员:Evdokia Anagnostou, MD、Holland Bloorview Kids Rehabilitation Hospital
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- PPF3-10-2025
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.